Practice patterns for oral corticosteroid burst therapy in the outpatient management of acute asthma exacerbations

Allergy and Asthma Proceedings

Volumn 33, Issue 1, 2012, Pages 82-89

  Fuhlbrigge, Anne L ^a   Lemanske, Robert F ^b   Rasouliyan, Lawrence ^c   Sorkness, Christine A ^b   Fish, James E ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ICON Late Phase and Outcomes Research   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; ASTHMA; CHILD; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTPATIENT CARE; PEDIATRICIAN; PHYSICIAN; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; SCHOOL CHILD;

EID: 84857483337     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3499     Document Type: Article

References (22)

1. Bai TR, Vonk JM, Postma DS, and Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 30:452- 456, 2007.
2. CONTROLLED trial of effects of cortisone acetate in status asthmaticus; report to the Medical Research Council by the subcommittee on clinical trials in asthma. Lancet 271:803- 806, 1956.
3. National Heart Lung and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR3): Guidelines for the diagnosis and management of asthma. 2007. Available online at www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm; accessed July 23, 2010.
4. Reddel HK, Taylor DR, Bateman ED, et al. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/ European Respiratory Society statement: Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 180:59 -99, 2009.
5. Fitzgerald JM, Becker A, Sears MR, et al., and the Canadian Asthma Exacerbation Study Group. Doubling the dose of budesonide vs. maintenance treatment in asthma exacerbations. Thorax 59:550 -556, 2004.
6. Garrett J, Williams S, Wong C, and Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child 79:12-17, 1998. (Pubitemid 28331246)
7. Oborne J, Mortimer K, Hubbard RB, et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: A randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med 180:598-602, 2009.
8. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 343:689-694, 2003.
9. Cydulka RK, and Emerman CL. A pilot study of steroid therapy after emergency department treatment of acute asthma: Is a taper needed? J Emerg Med 16:15-19, 1998. (Pubitemid 28087343)
10. Karan RS, Pandhi P, Behera D, et al. A comparison of non-tapering vs. tapering prednisone in acute exacerbation of asthma involving use of the low-dose ACTH test. Int J Clin Pharmacol Ther 40:256 -262, 2002.
11. O'Driscoll BR, Kalra S, Wilson M, et al. Double-blind trial of steroid tapering in acute asthma. Lancet 6:341:324 -327, 1993.
12. Verbeek PR, and Geerts WH. Nontapering vs. tapering prednisone in acute exacerbations of asthma: A pilot trial. J Emerg Med 13:715-719, 1995.
13. Lederle FA, Pluhar RE, Joseph AM, and Niewoehner DE. Tapering of corticosteroid therapy following exacerbation of asthma: A randomized, double-blind, placebo-controlled trial. Arch Intern Med 147:2201-2203, 1987. (Pubitemid 18008726)
14. Webb J, and Clark TJH. Recovery of plasma corticotrophin and cortisol levels after a three-week course of prednisolone. Thorax 36:22-24, 1981. (Pubitemid 11188670)
15. Zora JA, Zimmerman D, Carey TL, et al. Hypothalamic-pituitary- adrenal axis suppression after short-term high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 77:9 -13, 1986.
16. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 355:542-545, 2000. (Pubitemid 30088675)
17. Laan RF, van Riel PL, van de Putte LB, et al. Low-dose prednisolone induces rapid reversible axial bone loss inpatients with rheumatoid arthritis: A randomized, controlled study. Ann Intern Med 119:963-968, 1993. (Pubitemid 23334651)
18. Walsh LJ, Wong CA, Osborne J, et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56:279 -284, 2001.
19. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:704 -709, 1998.
20. Rea HR, Scragg R, Jackson R, et al. A case-control study of deaths from asthma. Thorax 41:833- 839, 1986.
21. Chang AB, Clark R, Sloots TP, et al. A 5- vs. 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: A randomised controlled trial. Med J Aust 189:306 -310, 2008.
22. Kayani S, and Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: A comparison of two doses of oral steroids. Chest 122:624 - 628, 2002.